GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.
about
Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammationGlucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseGLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease.Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.Review on the effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of non-alcoholic fatty liver disease.Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway.Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model.Exendin-4 attenuates brain death-induced liver damage in the rat.
P2860
Q31149434-450F952D-A740-4140-B979-D05F591DAD82Q33970970-68EB3596-C239-4B89-AD07-BAF5FC03B3A8Q34405101-EA30BC01-407D-4C70-B121-9B1AC34B56B4Q36465496-7E966233-36E2-4FE4-823F-F5AD02E2E03DQ36941601-F4C4EF12-42ED-4AF2-93C8-68AD8414F26AQ37596189-656AE629-60B9-4754-997F-A1D317098E80Q38234416-D579B700-F32A-4497-92EB-3B300536EA3EQ38445611-73FBC470-B59A-431F-9E06-5D9D8C28CC30Q38527138-FC1FE6FA-4C1F-41E4-96FD-02F2CD094B8AQ38955646-0507B14E-5CD1-4C87-A5D1-75AF834517ECQ41878667-F6FA5974-7C65-4AE2-B5AA-FD7336E9727DQ46116943-32E33693-C312-4C3B-BAA6-7185D6DE9BFDQ52150032-70A5B7CA-A40B-41CA-9D72-BA44EDE1C969
P2860
GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@en
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@nl
type
label
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@en
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@nl
prefLabel
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@en
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@nl
P2093
P2860
P356
P1433
P1476
GLP-1 analogue prevents NAFLD ...... knockdown by inhibiting c-JNK.
@en
P2093
Gangyi Yang
Guenther Boden
Huaidong Hu
Lili Zhang
Mengliu Yang
P2860
P304
P356
10.1111/LIV.12120
P577
2013-02-24T00:00:00Z